PARN

Chr 16ARAD

poly(A)-specific ribonuclease

Also known as: DAN, DKCB6, PFBMFT4

The protein encoded by this gene is a 3'-exoribonuclease, with similarity to the RNase D family of 3'-exonucleases. It prefers poly(A) as the substrate, hence, efficiently degrades poly(A) tails of mRNAs. Exonucleolytic degradation of the poly(A) tail is often the first step in the decay of eukaryotic mRNAs. This protein is also involved in silencing of certain maternal mRNAs during oocyte maturation and early embryonic development, as well as in nonsense-mediated decay (NMD) of mRNAs that contain premature stop codons. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismAR/ADLOEUF 0.522 OMIM phenotypes
Clinical SummaryPARN
🧬
Gene-Disease Validity (ClinGen)
pulmonary fibrosis and/or bone marrow failure, Telomere-related, 4 · SDDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.33) despite low pLI — interpret in context.
📋
ClinVar Variants
100 unique Pathogenic / Likely Pathogenic· 456 VUS of 998 total submissions
📖
GeneReview available — PARN
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.52LOEUF
pLI 0.000
Z-score 4.02
OE 0.33 (0.220.52)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
0.79Z-score
OE missense 0.88 (0.790.97)
285 obs / 325.3 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.33 (0.220.52)
00.351.4
Missense OE?0.88 (0.790.97)
00.61.4
Synonymous OE?0.93
01.21.6
LoF obs/exp: 14 / 42.2Missense obs/exp: 285 / 325.3Syn Z: 0.57
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitivePARN-related dyskeratosis congenitaLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.5575th %ile
GOF
0.4085th %ile
LOF
0.3647th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Literature Evidence

LOFWe found an additional new missense variant (encoding p.Lys421Arg) in a proband of European ancestry. PARN is among the 20% of genes with the lowest prevalence of rare variants that are likely to disrupt normal function (mutation-intolerant genes)14, consistent with the identified variants causing h1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 25848748

ClinVar Variant Classifications

998 submitted variants in ClinVar

Classification Summary

Pathogenic54
Likely Pathogenic46
VUS456
Likely Benign369
Benign32
Conflicting15
54
Pathogenic
46
Likely Pathogenic
456
VUS
369
Likely Benign
32
Benign
15
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
44
0
10
0
54
Likely Pathogenic
36
2
8
0
46
VUS
9
388
51
8
456
Likely Benign
0
2
221
146
369
Benign
0
2
30
0
32
Conflicting
15
Total89394320154972

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

15 pathogenic / likely-pathogenic (of 28) ClinVar copy-number / structural variants overlap PARN — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

PARN · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →